Vice President of Immuno-Oncology and Cell and Gene Therapy
at IQVIA
As vice president of immuno-oncology and CAGT at IQVIA Biotech, Erin is responsible for leading strategic direction to help sponsors meet their goals with high quality and delivery of our innovative services, solutions and expertise. As advancements in immuno-oncology and cell and gene therapies continue to transform patient care, Erin helps successfully guide sponsors through a dynamic landscape with strong therapeutic expertise and more than two decades of experience in global clinical research and drug development processes.
Areas of Expertise
Got a Question for Erin Finot?
Get in touch using the contact form linked here and we'll get back to you shortly.
